Learn more about the use of microdialysis in drug development through this AAPS Journal article.
Abstract
Adequate drug penetration to a site of infection is absolutely imperative to ensure sufficient antimicrobial treatment. Microdialysis is a minimally invasive, versatile technique, which can be used to study the penetration of an antiinfective agent in virtually any tissue of interest. It has been used to investigate drug distribution and pharmacokinetics in variable patient populations, as a tool in dose optimization, a potential utility in therapeutic drug management, and in the study of biomarkers of disease progression. While all of these applications have not been fully explored in the field of antiinfectives, this review provides an overview of how microdialysis has been applied in various phases of drug development, a focus on the specific applications in the subspecialties of infectious disease (treatment of bacterial, fungal, viral, parasitic, and mycobacterial infections), and developing applications (biomarkers and therapeutic drug management).
This article is part of The AAPS Journal theme Integrating Microdialysis and Imaging Tools in Systems Pharmacology. Read all articles in this theme online in The AAPS Journal.
Read full-text articles by logging into the AAPS website with your AAPS member credentials and clicking through on The AAPS Journal cover.